Acid-fast bacilli persisting in the genitourinary tract 3 years after intravesical bacille Calmette-Guérin therapy for bladder carcinoma.
Hurle
R
R
Division of Urology, Ospedali Riuniti di Bergamo, Italy.
Losa
A
A
Ranieri
A
A
Lembo
A
A
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000368:Aged; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000009:adverse effects*; D002278:Carcinoma in Situ / Q000628:therapy*; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D012293:Rifampin / Q000627:therapeutic use; D014389:Tuberculosis, Male Genital / Q000188:drug therapy / Q000209:etiology*; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D000276:Adjuvants, Immunologic; D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D001500:BCG Vaccine; D007538:Isoniazid; D012293:Rifampin